Loading clinical trials...

Placenta Accreta : Contrast-enhanced Ultrasound Analysis in High Risk Population | Clinical Trials | Clareo Health

COMPLETEDNANCT02302573

Placenta Accreta : Contrast-enhanced Ultrasound Analysis in High Risk Population

Abnormally invasive placenta (AIP) is defined as an abnormal placental attachment of a part or the entire chorionic plate with penetration of chorionic villi in the myometrium and absence of the decid...

Lead sponsor: University Hospital, Tours•2 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGNA

High vs. Low Segmental Hysterotomy: Impact on Uterine Wall Defects Post-Cesarean

NCT06620432 · Placenta Accreta Spectrum

RECRUITINGNA

Placenta Accreta Spectrum Outcome After Uterine Conservation

NCT04866888 · Placenta Accreta Spectrum

Active Not RecruitingNA

Conservative Management for PAS Pilot

NCT05139498 · Placenta Accreta

Not Yet Recruiting

Spinal Versus General Anesthesia in Pregnancies With Placenta Accreta Spectrum: A Retrospective Comparative Study

NCT07406841 · Placenta Accreta Spectrum

Not Yet Recruiting

Ultrasound Model to Help Differentiate Between Placenta Accreta Spectrum and Uterine Dehiscence in 3rd Trimester Pregnancies

NCT07236060 · Placenta Accreta, Third Trimester, Uterine Scar Dehiscence

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 26, 2025Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment80

Start dateMay 2009

Last updatedDec 26, 2025

Condition

Placenta Accreta

Locations shown

CHU La Millétrie

Poitiers

University Hospital of Tours

Tours

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 26, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions